Clinical importance of thoracal lymphadenopathy in COVID-19.

Hans-Jonas Meyer,Bohdan Melekh,Andreas Wienke,Jan Borggrefe,Alexey Surov

Journal of infection and public health（2023）

引用 0|浏览0

暂无评分

摘要

Thoracal lymphadenopathy comprising cumulative size and affected levels derived from CT images is associated with 30-day mortality in patients with COVID-19. COVID-19 patients presenting with thoracic lymphadenopathy should be considered as a risk group.

查看译文

关键词

thoracal lymphadenopathy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要